Updated Jul 16, 2026
GENERAL ATLANTIC, L.P. has filed 2 SEC Form 4 filings across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $157.01M. Lifetime open-market sales: $802.32M. Historical track record: 3/5 stars across 9 tracked purchases.

| Role | Director, 10% Owner |
|---|---|
| Notability | 30/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★☆☆ (3/5) |
|---|---|
| Total purchases tracked | 9 |
| Purchases with forward-return data | 9 |
| 30-day win rate | 5556% |
| 90-day win rate | 0% |
| Avg 5-day return | +126.56% |
| Avg 30-day return | +475.98% |
| Avg 90-day return | -1051.91% |
| Best 30-day return | +2192.64% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-15 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 675.0K | $16.49 | $11.13M |
| 2026-05-15 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 550.0K | $16.63 | $9.15M |
| 2026-05-15 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 750.0K | $16.87 | $12.65M |
| 2026-05-07 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 844.8K | $16.63 | $14.05M |
| 2026-05-07 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 700.0K | $16.84 | $11.79M |
| 2026-05-07 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 521.8K | $16.92 | $8.83M |
| 2026-03-17 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 500.0K | $18.33 | $9.16M |
| 2026-03-12 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 900.0K | $18.41 | $16.57M |
| 2026-03-12 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 1.10M | $17.56 | $19.38M |
| 2026-03-12 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 842.3K | $17.35 | $14.61M |
| 2025-09-17 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 6.25M | $16.01 | $100.00M |
| 2025-09-12 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 13.46M | $16.01 | $215.49M |
| 2025-08-11 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 129.4K | $22.54 | $2.92M |
| 2025-08-11 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 100.0K | $22.31 | $2.23M |
| 2025-08-11 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 516.8K | $21.46 | $11.09M |
| 2025-08-11 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 400.0K | $20.73 | $8.29M |
| 2025-08-11 | ALKT | ALKAMI TECHNOLOGY, INC. | P — Open-market purchase | 250.0K | $20.65 | $5.16M |
| 2025-05-19 | ALHC | Alignment Healthcare, Inc. | S — Open-market sale | 17.00M | $15.28 | $259.76M |
| 2024-11-27 | ALKT | ALKAMI TECHNOLOGY, INC. | S — Open-market sale | 3.00M | $39.75 | $119.25M |
| 2024-11-12 | ALKT | ALKAMI TECHNOLOGY, INC. | S — Open-market sale | 375.0K | $37.50 | $14.06M |
GENERAL ATLANTIC, L.P. is a corporate insider — currently tracked as Director, 10% Owner of ALKAMI TECHNOLOGY, INC. (ALKT). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 15 open-market purchases ($157.01M) and 6 open-market sales ($802.32M) across all tracked filings.
Across 9 tracked purchases, GENERAL ATLANTIC, L.P. averaged +476.0% avg 30-day return with a 5556% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GENERAL ATLANTIC, L.P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.